Mie University · University Hospital · 准教授

Research keywordsAlport syndrome・podocyte biology・focal segmental glomerulosclerosis・tubulointerstitial nephritis・glomerular filtration barrier・Crb2・Rhophilin-1・diabetic nephropathy

This is a public-data preview. Personalized fit, contact angles, and saved workflows require sign-in.

• Podocyte-specific Crb2 knockout mice develop focal segmental glomerulosclerosis. Tanoue A, Katayama K, et al. Sci Rep. 2021 Oct 15;11(1):20556.2021 · 主な業績等
• Mother-Son Kidney Transplantation in Patients With X-Linked Alport Syndrome. Katayama K, et al. Kidney Int Rep. 2021;6(5):1454-1458.2021 · 主な業績等
• Minimal change disease with thrombotic microangiopathy following the Pfizer-BioNTech COVID-19 vaccine. Tanaka F, Katayama K, et al. Clin Kidney J. 2021;15(3):567-568.2021 · 主な業績等
• Role of Liver Transplantation in Tolvaptan-Associated Acute Liver Failure. Endo M, Katayama K, et al. Kidney Int Rep. 2019;4(11):1653-1657.2019 · 主な業績等

• 難治性ネフローゼの糸球体硬化病変を惹起させるシグナルパスウェイの同定
• 巣状糸球体硬化症発症におけるポドサイト特異的遺伝子CRB2の機能解明
• 前向き研究に向けたIgA腎症の組織学的重症度分類の解析プラットフォームの構築
• 腎組織SGLT2とAT1R-NHE3経路の相互作用による心不全進展機序の解明

• Official profile
• ORCID